Table 2 IR of AP by circulating TG concentration and history of hospitalization for AP

 Overall

7,119,195

5686

0.08 (0.08–0.08)

 TGs < 2.26 mmol/L (< 200 mg/dL)

5,914,102

4111

0.07 (0.07–0.07)

Reference

 TGs ≥2.26–≤5.64 mmol/L (≥200–≤500 mg/dL)

1,111,737

1194

0.11 (0.10–0.11)

1.55 (1.45–1.65)

 TGs > 5.65–≤9.94 mmol/L (> 500–≤880 mg/dL)

72,665

169

0.23 (0.20–0.27)

3.35 (2.87–3.90)

 TGs > 9.94 mmol/L (> 880 mg/dL)

20,691

212

1.02 (0.89–1.17)

14.74 (12.84–16.92)

 TGs > 11.29 mmol/L (> 1000 mg/dL)

15,281

185

1.21 (1.05–1.40)

17.42 (15.03–20.18)

 Overall

7,115,037

5169

0.07 (0.07–0.07)

 TGs < 2.26 mmol/L (< 200 mg/dL)

5,911,134

3777

0.06 (0.06–0.07)

Reference

 TGs ≥2.26–≤5.65 mmol/L (≥200–≤500 mg/dL)

1,110,849

1079

0.10 (0.09–0.10)

1.52 (1.42–1.63)

 TGs > 5.65–≤9.94 mmol/L (> 500–≤880 mg/dL)

72,541

151

0.21 (0.18–0.24)

3.26 (2.77–3.83)

 TGs > 9.94 mmol/L (> 880 mg/dL)

20,513

162

0.79 (0.68–0.92)

12.36 (10.56–14.46)

 TGs > 11.29 mmol/L (> 1000 mg/dL)

15,119

138

0.91 (0.77–1.08)

14.28 (12.05–16.93)

 Overall

3681

374

10.16 (9.1–11.2)

 TGs < 2.26 mmol/L (< 200 mg/dL)

2657

246

9.26 (8.20–10.44)

Reference

 TGs ≥2.26–≤5.65 mmol/L (≥200–≤500 mg/dL)

778

86

11.05 (8.98–13.52)

1.19 (0.93–1.53)

 TGs > 5.65–≤9.94 mmol/L (> 500–≤880 mg/dL)

105

10

9.52 (4.91–17.22)

1.03 (0.55–1.94)

 TGs > 9.94 mmol/L (> 880 mg/dL)

141

32

22.70 (16.25–30.66)

2.45 (1.70–3.54)

 TGs > 11.29 mmol/L (> 1000 mg/dL)

127

30

23.62 (16.74–32.14)

2.55 (1.75–3.73)

 Overall

477

143

29.98 (25.1–34.9)

 TGs < 2.26 mmol/L (< 200 mg/dL)

311

88

28.30 (23.43–33.71)

Reference

 TGs ≥2.26–≤5.65 mmol/L (≥200–≤500 mg/dL)

110

29

26.36 (18.63–35.78)

0.93 (0.61–1.42)

 TGs > 5.65–≤9.94 mmol/L (> 500–≤880 mg/dL)

19

8

42.11 (21.12–66.03)

1.49 (0.72–3.07)

 TGs > 9.94 mmol/L (> 880 mg/dL)

37

18

48.65 (32.24–65.33)

1.72 (1.04–2.85)

 TGs > 11.29 mmol/L (> 1000 mg/dL)

35

17

48.57 (31.72–65.72)

1.72 (1.02–2.89)